The U.S. Food and Drug Administration authorized a booster of the Pfizer Inc and BioNTech COVID-19 vaccine for those 65 and older, all people at high risk of severe disease, et al. who are regularly exposed to the virus. The decision paves the way for a fast rollout of the booster shots as soon as in the week for many people that had their second dose […]